Could psychedelics help heal addiction, depression and obesity With Mark Haden and Adi Zuloff-Shani [Ep. 169]

Beyond Sugar Freedom Podcast

Could overcoming addiction be as simple as taking a pill?
And what if psychedelics could be our gateway into healing mental health and obesity struggles?
Today’s conversation is nothing short of fascinating.
Join me and special guest Mark Haden and Adi Zuloff-Shani from Clearmind Medicine as we dive deep into the current landscape of psychedelics in the health and wellness space.
They share about an incredible new molecule that is currently starting clinical trials and showing promising lasting effects on addiction, depression and obesity.
Mark Haden

Mark Haden is a trailblazer in the field of psychedelic medicine, currently serving as Director of Clinical Research at Psygen and Adjunct Professor at the University of British Columbia School of Population and Public Health. He was a co-founder and spent 10 years as Executive Director of the renowned Multidisciplinary Association for Psychedelic Studies Canada (MAPS).
Haden has dedicated the last 30 years to public education and training on drugs and drug policy, including advising the Health Officers Council of British Columbia on the issues of a regulated market for all currently illegal drugs as well as working with Addiction Services in counselling and supervisory roles. He is a frequent keynote speaker and distinguished author on the issues of drug control policy and psychedelics and was awarded the Queen's Diamond Jubilee Medal for his work on drug policy reform in 2013.
Adi Zuloff-Shani, PhD
Chief Executive Officer at Clearmind Medicine
Dr. Adi Zuloff-Shani is a Biomedical Research and Development Executive with a vast experience with over 20 years of strategic and operational leadership in the healthcare industry and a deep understanding of therapeutics development in heavily regulated environments.
She has expertise in the Pharmaceutical industry, leading cell and drug development through drug and product development, CMC, non-clinical, all stages of clinical development, as well as clinical development strategies and regulatory (FDA, EMEA, others) interactions, NDAs, leading INDs, as well as parallel EU activities. Dr. Zuloff-Shani holds a Ph.D. in human biology and immunology from Bar-Ilan University, Israel.
******************
Connect with Clearmind Medicine Team:
Facebook: https://www.facebook.com/ClearmindMedicine
Twitter: https://twitter.com/ClearmindCMND
YouTube: https://www.youtube.com/channel/UCg_JDmUZSqstavsbd3zYmmg
Instagram: https://www.instagram.com/clearmindmed/
LinkedIn: https://ca.linkedin.com/company/clearmind-medicine
******************
➠ Discover the unique ROOT CAUSE that is keeping you stuck on the sugar rollercoaster every year. Take the QUIZ HERE NOW.
➠ Ready to finally kick your emotional eating habit and build a new healthy relationship with sugar from the inside out? Say goodbye to late night snacking and stress eating for good. Get immediate access to my exclusive and FREE Kick Emotional Eating 3 Part Training here.

******************
Come hang out with me and keep the conversation going on social media:
Instagram: https://www.instagram.com/danielledaem/